# The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling

> **NCT01340326** · PHASE4 · COMPLETED · sponsor: **Dong-A University** · enrollment: 800 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** high dose of valsartan
- **DRUG:** usual dose of valsartan

## Key facts

- **NCT ID:** NCT01340326
- **Lead sponsor:** Dong-A University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 800 (ACTUAL)
- **Last updated:** 2015-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01340326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01340326, "The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01340326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*